Cargando…

Clinical usefulness of new noninvasive serum biomarkers for the assessment of liver fibrosis and steatosis in children with chronic hepatitis C

AIM OF THE STUDY: Recently, novel serum markers modified by the body mass index z-score (BMI z-score) were proposed as a reliable noninvasive alternative for the detection of significant fibrosis and steatosis in children with chronic hepatitis C (CHC). The aim of this study was to evaluate the clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pokorska-Śpiewak, Maria, Kowalik-Mikołajewska, Barbara, Aniszewska, Małgorzata, Pluta, Magdalena, Marczyńska, Magdalena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2017
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731428/ https://www.ncbi.nlm.nih.gov/pubmed/29255808 http://dx.doi.org/10.5114/ceh.2017.71337

Ejemplares similares

Novel serum biomarkers modified by the body mass index z-score for the detection of liver fibrosis and steatosis in children with chronic hepatitis C
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2017)

Liver steatosis in children with chronic hepatitis B and C: Prevalence, predictors, and impact on disease progression
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2017)

Non-invasive evaluation of the liver disease severity in children with chronic viral hepatitis using FibroTest and ActiTest – comparison with histopathological assessment
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2017)

The influence of hepatitis B and C virus coinfection on liver histopathology in children
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2014)

Real-Life Experience with Ledipasvir/Sofosbuvir for the Treatment of Chronic Hepatitis C Virus Infection with Genotypes 1 and 4 in Children Aged 12 to 17 Years—Results of the POLAC Project
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2021)

One-Year Outcomes after Ledipasvir/Sofosbuvir Treatment of Chronic Hepatitis C in Teenagers with and without Significant Liver Fibrosis—A Case Series Report
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2021)

The Influence of Treatment with Ledipasvir/Sofosbuvir on Growth Parameters in Children and Adolescents with Chronic Hepatitis C
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2022)

HBV and HCV Infection in Children and Adolescents
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2023)

Non-Vertical Exposures to HIV, HBV and HCV Infection in Children and Adolescents—Risk of Infection, Standards of Care and Postexposure Prophylaxis
por: Tomasik, Anna, et al.
Publicado: (2021)

Real-World Efficacy and Safety of an 8-Week Glecaprevir/Pibrentasvir Regimen in Children and Adolescents with Chronic Hepatitis C—Results of a Multicenter EpiTer-2 Study
por: Pawlowska, Malgorzata, et al.
Publicado: (2023)

Acute Hepatitis B and Unusual Follow-Up in a 16-Year-Old Boy: Case Report
por: Bieńkowski, Carlo, et al.
Publicado: (2021)

Prevalence and predictors of liver disease in HIV-infected children and adolescents
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2017)

Comparison of clinical severity and epidemiological spectrum between coronavirus disease 2019 and influenza in children
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2021)

Testing for HIV Increases the Odds of Correct Fetal Ultrasound Result
por: Bieńkowski, Carlo, et al.
Publicado: (2022)

Epstein Barr Virus Hepatitis—A Mild Clinical Symptom or a Threat?
por: Rutkowska, Magdalena, et al.
Publicado: (2023)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
por: Ahn, Sang Bong
Publicado: (2023)

The prevalence and predictors of pulmonary lesions in paediatric patients with coronavirus disease 2019 – a brief report
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2022)

Analysis of Preventable Risk Factors for Toxoplasma gondii Infection in Pregnant Women: Case-Control Study
por: Bieńkowski, Carlo, et al.
Publicado: (2022)

Management of hepatitis C in children and adolescents during COVID-19 pandemic
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2020)

Noninvasive serum biomarkers for liver fibrosis in NAFLD: current and future
por: Reinson, Tina, et al.
Publicado: (2023)

Nonalcoholic Fatty Liver Disease: Noninvasive Methods of Diagnosing Hepatic Steatosis
por: AlShaalan, Rasha, et al.
Publicado: (2015)

Predicting Hepatic Steatosis in Living Liver Donors via Noninvasive Methods
por: Kim, Jong Man, et al.
Publicado: (2016)

Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
por: Mikolasevic, Ivana, et al.
Publicado: (2021)

Metabolic Stress Index Including Mitochondrial Biomarker for Noninvasive Diagnosis of Hepatic Steatosis
por: Chang, Jae Seung, et al.
Publicado: (2022)

Comparison of hepatic steatosis index as noninvasive diagnostic tool and liver ultrasound for non-alcoholic steatosis in the adult population
por: Khani, Vahid, et al.
Publicado: (2022)

Noninvasive Biomarkers in Assessment of Liver Fibrosis in Patients with HBeAg Negative Chronic Hepatitis B
por: Dimzova, Marija, et al.
Publicado: (2018)

Noninvasive Evaluation of Liver Fibrosis in Patients with Chronic Hepatitis C
por: Ladero, Jose M.
Publicado: (2011)

Efficacy and Safety of the Treatment of Chronic Hepatitis C with Sofosbuvir/Ledipasvir in Children Aged 5 to 10 Years with Comorbidities—A Brief Report
por: Pokorska-Śpiewak, Maria, et al.
Publicado: (2022)

Association between Noninvasive Fibrosis Markers and Cardio-Vascular Organ Damage among Adults with Hepatic Steatosis
por: Sesti, Giorgio, et al.
Publicado: (2014)

Is endocan a novel potential biomarker of liver steatosis and fibrosis?
por: Klisić, Aleksandra, et al.
Publicado: (2020)

Serum Hyaluronic Acid as a Noninvasive Marker of Hepatic Fibrosis in Chronic Hepatitis B
por: Geramizadeh, Bita, et al.
Publicado: (2008)

Serum MicroRNA Levels as a Noninvasive Diagnostic Biomarker for the Early Diagnosis of Hepatitis B Virus-Related Liver Fibrosis
por: Bao, Suxia, et al.
Publicado: (2017)

Potential role of noninvasive biomarkers during liver fibrosis
por: Kaur, Navneet, et al.
Publicado: (2021)

Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis
por: Yoo, Jeongin, et al.
Publicado: (2020)

Noninvasive assessment of paediatric hepatic steatosis by using attenuation imaging
por: Hwang, Sook Min, et al.
Publicado: (2023)

Serum NX-DCP as a New Noninvasive Model to Predict Significant Liver Fibrosis in Chronic Hepatitis C
por: Saito, Masaya, et al.
Publicado: (2015)

Serum Gamma-Glutamyl Transpeptidase-to-Platelet Ratio as a Noninvasive Marker of Liver Fibrosis in Chronic Hepatitis B
por: Purkayastha, Subham, et al.
Publicado: (2023)

A noninvasive diagnostic model to assess nonalcoholic hepatic steatosis in patients with chronic hepatitis B
por: Ou, Hongjie, et al.
Publicado: (2016)

Hepatic Steatosis and Fibrosis in Chronic Inflammatory Bowel Disease
por: Veltkamp, Claudia, et al.
Publicado: (2022)

Hepatic Fibrosis and Steatosis in Metabolic Syndrome
por: Gangireddy, Venu Gopala Reddy, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_l0354jhj46ioh460lsk111rj7t